PARIS--(Marketwire - September 17, 2008) - Cegedim, the world leader in CRM for the pharmaceuticals industry, announces first-half 2008 revenues of EUR 414m, up 28%, a growing ordinary EBITDA of EUR 76m (18.4% of total revenues), an operating margin excluding exceptional charges and restructuring and integration costs of EUR 48m (11.4% of total revenues) and an ordinary operating margin of EUR 43m (10.4% of total revenues) in line with its expectations.As a result, the Group confirms that Dendrite’s integration has been a success and that all Group’s businesses are strongly growing.
